Search by keyword
Search by category
Search by poster
See all posts→Popular articles
-
-
Japan: Lecanemab drug price determined/out-of-pocket expense is about 140,000 JPY per year
-
ランセット:認知症の新たなリスク要因を2つ特定し、45%の症例は遅らせたり、軽減したりできる可能性があると提言しています。
-
“What I can do now that I have dementia” by Tomofumi Tanno
-
About Alzheimer’s Association Japan
-
New study predicts the number of people living with Alzheimer’s disease to triple by 2050
-